Dabur India Ltd, a major packaged consumer goods company in India, is planning to diversify into new markets such as therapeutics and baby care, according to analysts who spoke with the company’s management. The expansion includes entering the Rs 11.4 billion Baby Care market under the brand ‘Dabur Baby.’ Additionally, Dabur is eyeing a target revenue of Rs 5,000 crores in the mid to long term for its therapeutics division, focusing on newer therapy and nutraceutical segments. The company aims to grow double-digit by capitalizing on doctors’ openness to prescribing medicines from different systems. Dabur also intends to premiumize its portfolio and align it with emerging trends.